Global Migraine – Epidemiology EpiCast Report: Forecast to 2026

“The Report EpiCast Report: Migraine – Epidemiology Forecast to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

About Migraine – Epidemiology Market

Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the condition worldwide, and it is therefore recognized as a high-priority public health problem by the World Health Organization.

Get Sample copy of this Report @

In 2016, there were 73,914,635 total prevalent cases of migraine in adults ages 18 years and older in the 7MM. The US had the most cases, while Spain had the fewest. In the 7MM, the number of total prevalent cases of migraine is expected to grow to 74,543,569 by 2026, at an Annual Growth Rate (AGR) of 0.09%. Since age- and ***-specific prevalence was held constant throughout the forecast period, all changes in the total prevalent cases of migraine are the result of demographic changes. GlobalData epidemiologists estimate that 1.61% of total migraine cases in the 7MM in 2016 were CM.

This forecast is supported by country-specific prevalence studies for each market, most of which are based on nationally representative samples. GlobalData epidemiologists are confident that these sources provide the most accurate and robust data available in each market. Additionally, GlobalData epidemiologists used consistent methodology while creating forecasts for each market. This allows useful and accurate comparisons regarding total prevalent cases of migraine between markets.


– The Migraine EpiCast Report provides an overview of the risk factors and global trends of migraine in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases of migraine segmented by *** and age (for ages 18 years and older) in these markets. This forecast is further segmented by migraine frequency into episodic migraine (EM) and chronic migraine (CM).

– The migraine epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

– The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

View Sample PDF @

Reasons to buy

The Migraine EpiCast report will allow you to –

– Develop business strategies by understanding the trends shaping and driving the global migraine market.

– Quantify patient populations in the global migraine market to improve product design, pricing, and launch plans.

– Organize sales and marketing efforts by identifying the age groups and *** that present the best opportunities for migraine therapeutics in each of the markets covered.

– Identify the percentage of migraine prevalent cases by frequency.

View Report @

Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Executive Summary 4

2.1 Related Reports 5

2.2 Upcoming Reports 5

3 Epidemiology 6

3.1 Disease Background 6

3.2 Risk Factors and Comorbidities 6

3.3 Global and Historical Trends 9

3.3.1 US 10

3.3.2 5EU 11

3.3.3 Japan 11

3.4 Forecast Methodology 11

3.4.1 Sources 12

3.4.2 Forecast Assumptions and Methods 14

3.5 Epidemiological Forecast for Migraine (2016-2026) 17

3.5.1 Total Prevalent Cases of Migraine 17

3.5.2 Age-Specific Total Prevalent Cases of Migraine 18

3.5.3 ***-Specific Total Prevalent Cases of Migraine 19

3.5.4 Migraine Cases by Frequency of Occurrences 20

3.6 Discussion 21

3.6.1 Epidemiological Forecast Insight 21

3.6.2 Limitations of Analysis 22

3.6.3 Strengths of Analysis 23

4 Appendix 24

4.1 Bibliography 24

4.2 About the Authors 28

4.2.1 Epidemiologist 28

4.2.2 Reviewers 28

4.2.3 Global Director of Therapy Analysis and Epidemiology 29

4.2.4 Global Head and EVP of Healthcare Operations and Strategy 29

4.3 About GlobalData 30

4.4 Contact Us 30

4.5 Disclaimer 30

1.1 List of Tables

Table 1: Risk Factors and Comorbidities for Migraine 8

Table 2: ICHD-3 Diagnostic Criteria for Migraine 12

Table 3: Total Prevalent Cases of Migraine, Ages 18 Years, Both Sexes, N, Select Years 2016-2026 18

1.2 List of Figures

Figure 1: 7MM, Total Prevalent Cases of Migraine, Both Sexes, Ages 18 Years, 2016 and 2026 5

Figure 2: 7MM, Age-Standardized Total Prevalence of Migraine, Both Sexes, Ages 18 Years, 2016 10

Figure 3: Sources Used and Not Used in Epidemiological Analysis of Migraine Prevalence 13

Figure 4: Sources Used and Not Used in Epidemiological Analysis of Migraine Frequency 14

Figure 5: 7MM, Age-Specific Total Prevalent Cases of Migraine, Both Sexes, Ages 18 Years, 2016 19

Figure 6: 7MM, ***-Specific Total Prevalent Cases of Migraine, Ages 18 Years, 2016 20

Figure 7: 7MM, Total Prevalent Migraine Cases by Frequency of Occurrences, Both Sexes, Ages 18 Years, 2016 21

Send An Enquiry Request @

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by
%d bloggers like this: